ExploreTreatments
Updated: November 10, 2026 · By Charly P. · Reviewed by Ved P. · Not a medical review

Embody vs MedVi: $49 vs $99 Semaglutide

Embody is $49/mo vs MedVi at $99/mo for semaglutide. Compare the 12-month cost, medication formats and commitment terms before you sign up.

Disclosure: Some links on this page are affiliate links. We may earn a commission if you purchase through them, at no extra cost to you.

Quick Verdict

Editorial Take

Best Overall: Embody, on cost. Embody is $50/month cheaper on semaglutide than MedVi, which compounds to $600 over twelve months — a real gap rather than a rounding difference.

Best for Budget: Embody. Embody is $50/month cheaper on semaglutide than MedVi, which compounds to $600 over twelve months — a real gap rather than a rounding difference.

Best for Fast Approval: Both run fully online intake with licensed clinician review, so approval speed is unlikely to separate them. Embody quotes shipping as free, 1–2 days; MedVi quotes free.

At a Glance Comparison

FeatureEmbodyMedVi
Semaglutide price$49/month$99/month
Tirzepatide price$99/monthNot published before intake
Needle-free oral optionNoNo
Brand-name medicationNoNo
Insurance supportNoNo
ShippingFree, 1–2 daysFree

Who Should Choose Embody

Choose Embody if:

  • ✓You want the lowest advertised monthly rate on both molecules
  • ✓You are comparing on a published semaglutide rate of $49/month
  • ✓You accept the trade-off that the lowest rates require paying twelve months up front

Who Should Choose MedVi

Choose MedVi if:

  • ✓You want 24/7 access to certified medical professionals and same-day approval
  • ✓You are comparing on a published semaglutide rate of $99/month
  • ✓You accept the trade-off that the $99 price covers the first month only, and refills cost roughly double

Embody Deep Dive

Embody leads with the lowest advertised monthly rate on both molecules. Semaglutide is published at $49/month, tirzepatide at $99/month. The honest caveat is that the lowest rates require paying twelve months up front.

How It Works

  1. Complete the online intake covering health history and weight goals
  2. A licensed clinician reviews your information and prescribes if appropriate
  3. Medication ships — free, 1–2 days
  4. Continue with clinician support for dose adjustment

Medications Offered

  • ✓Semaglutide from $49/month
  • ✓Tirzepatide from $99/month

Pricing

$49/month semaglutide, though the $49 semaglutide and $99 tirzepatide rates are 12-month prepaid sale prices ($588 and $1,188 up front) through December 1; month-to-month is $79 and $129. Free, 1–2 days.

Pros
  • ✓The lowest advertised monthly rate on both molecules
  • ✓Free, 1–2 days
Cons
  • ✗The lowest rates require paying twelve months up front
  • ✗Compounded medication is not an FDA-approved finished product

MedVi Deep Dive

MedVi leads with 24/7 access to certified medical professionals and same-day approval. Semaglutide is published at $99/month. The honest caveat is that the $99 price covers the first month only, and refills cost roughly double.

How It Works

  1. Complete the online intake covering health history and weight goals
  2. A licensed clinician reviews your information and prescribes if appropriate
  3. Medication ships — free
  4. Continue with clinician support for dose adjustment

Medications Offered

  • ✓Semaglutide from $99/month

Pricing

$99/month semaglutide, though the $99 rate is a first-month price; refills are $199. Free.

Pros
  • ✓24/7 access to certified medical professionals and same-day approval
  • ✓Free
Cons
  • ✗The $99 price covers the first month only, and refills cost roughly double
  • ✗Compounded medication is not an FDA-approved finished product

Honest Tradeoffs

Pricing

Embody is $50/month cheaper on semaglutide than MedVi, which compounds to $600 over twelve months — a real gap rather than a rounding difference.

Medication Types

Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.

Doctor Involvement

Both require review by a licensed U.S. clinician before dispensing, and neither is a subscribe-and-ship product. Ongoing support for dose titration is included at both.

Delivery Speed

Embody: Free, 1–2 days. MedVi: Free. In practice the gap between clinician review times usually matters more than the shipping estimate.

Subscription Model

Both headline rates come with strings: for Embody, the $49 semaglutide and $99 tirzepatide rates are 12-month prepaid sale prices ($588 and $1,188 up front) through December 1; month-to-month is $79 and $129; for MedVi, the $99 rate is a first-month price; refills are $199. Compare what each costs month-to-month, not just the advertised figure.

Pricing Breakdown

AspectEmbodyMedVi
Semaglutide, monthly$49/month$99/month
Tirzepatide, monthly$99/monthNot published before intake
6-month semaglutide total$294$594
12-month semaglutide total$588$1,188
Commitment required for best rateYesYes

What You Actually Pay Over 12 Months

Advertised starting prices are the least useful number in this comparison, so below is what each provider costs across a realistic course of treatment rather than on day one. Pricing verified November 10, 2026; confirm the final figure at enrollment, as offers change.

EmbodyMedVi
First month$49/month$99/month
6-month total$294$594
12-month total$588$1,188
Price includesMedication, clinician review and ongoing dose support. Shipping: free, 1–2 days.Medication, clinician review and ongoing dose support. Shipping: free.
What can raise itThe advertised rate is conditional — the $49 semaglutide and $99 tirzepatide rates are 12-month prepaid sale prices ($588 and $1,188 up front) through December 1; month-to-month is $79 and $129.The advertised rate is conditional — the $99 rate is a first-month price; refills are $199.

Embody is $50/month cheaper on semaglutide than MedVi, which compounds to $600 over twelve months — a real gap rather than a rounding difference. Both headline rates come with strings: for Embody, the $49 semaglutide and $99 tirzepatide rates are 12-month prepaid sale prices ($588 and $1,188 up front) through December 1; month-to-month is $79 and $129; for MedVi, the $99 rate is a first-month price; refills are $199. Compare what each costs month-to-month, not just the advertised figure. Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.

Medication Comparison

Semaglutide

Embody is $50/month cheaper on semaglutide than MedVi, which compounds to $600 over twelve months — a real gap rather than a rounding difference.

Tirzepatide

Tirzepatide pricing is not published by both providers, so the dual-agonist comparison cannot be made from public information. Ask at intake if tirzepatide is what you want.

Which Provider Offers What

Both are injection-only, so if you want a needle-free tablet neither of these is the answer. Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.

Results Expectations

Both dispense the same active ingredients at clinician-determined doses, so there is no evidential basis for expecting different weight outcomes from one over the other. Published trial results for semaglutide and tirzepatide describe the molecules, not the telehealth platform prescribing them, and compounded formulations have not been through trials of their own. Adherence, dose titration and the lifestyle changes made alongside treatment will drive your result far more than this choice will.

Safety Considerations

Side Effects

Both carry the GLP-1 side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, typically dose-related and most pronounced during titration. GLP-1 medications carry serious warnings including the risk of thyroid C-cell tumours and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Disclose your full history at intake.

Doctor Supervision

Both require review by a licensed U.S. clinician before dispensing and provide ongoing support for dose adjustment.

Prescription Requirement

Both dispense compounded semaglutide or tirzepatide. Neither is an FDA-approved finished product, and neither has independent trial evidence for its specific formulation, though both use the same active ingredients as the branded medications.

How We Evaluated These Providers

We evaluated both providers based on the following criteria:

  • ✓Published monthly pricing for each molecule, and the six and twelve-month totals that follow from it
  • ✓Whether the advertised rate requires a prepaid term
  • ✓Medication formats offered, including any needle-free option
  • ✓Regulatory status: compounded against FDA-approved brand-name
  • ✓Whether insurance can be used at all
  • ✓Shipping as published by each provider

Final Verdict

Editorial Take

Best for Budget Users

Embody. Embody is $50/month cheaper on semaglutide than MedVi, which compounds to $600 over twelve months — a real gap rather than a rounding difference.

Best for Fast Results

Tied, and neither should claim otherwise. Same molecules, comparable clinician-led process; the pace of results depends on titration and adherence rather than the provider.

Best for Doctor Supervision

Comparable. Both require licensed clinician review before dispensing and include ongoing dose support.

Best Premium Experience

Embody for the lowest advertised monthly rate on both molecules; MedVi for 24/7 access to certified medical professionals and same-day approval. Which reads as premium depends on whether you value the programme around the medication or the lowest number on the invoice.

Frequently Asked Questions

Read Our Full Reviews

Related Comparisons

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.